Advertisement

Cytotechnology

, Volume 63, Issue 1, pp 41–47 | Cite as

Increasing batch-to-batch reproducibility of CHO cultures by robust open-loop control

  • M. Aehle
  • A. Kuprijanov
  • S. Schaepe
  • R. Simutis
  • A. LübbertEmail author
Original Research

Abstract

In order to guarantee the quality of recombinant therapeutic proteins produced in mammalian cell systems, the straightforward approach in industry is to run the processes as reproducible as possible. It is first shown that considerable distortions in the currently operated processes appear when the initial cell density deviates from its nominal value. Small deviations in the initial cell mass may lead to severe deviations from the desired biomass trajectory. Next, it is shown how to design a fed-batch production process in such a way that it is robust with respect to variations in the viable cell density. A simple open loop strategy is proposed for that purpose. Here we show for the first time at animal cell cultures (CHO cells) that by means of an appropriate glutamine feed rate profile F(t), which keeps the specific growth rate of the cells on a predefined value below its maximal value while maintaining the viabilities on a high level, the diverging viable cell count profiles change over into a robust converging set of profiles. The CHO cells used to validate the procedure could be focused to any specific growth rates below μmax.

Keywords

Mammalian cell culture Process reproducibility Open loop control Quality by design 

Notes

Acknowledgments

The financial support from the “Excellence Initiative” of the German federal state “Sachsen-Anhalt” is gratefully acknowledged.

References

  1. Ansorge S, Esteban G, Schmid G (2010) On-line monitoring of responses to nutrient feed additions by multi-frequency permittivity measurements in fed-batch cultivations of CHO cells. Cytotechnology 62:121–132CrossRefGoogle Scholar
  2. Butler M (2005) Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals. Appl Microbiol Biotechnol 68(3):283–291CrossRefGoogle Scholar
  3. Charaniya S, Le H, Rangwala H, Mills K, Johnsonc K, Karypis G, Hu WS (2010) Mining manufacturing data for discovery of high productivity process characteristics. J Biotechnol 147:186–197CrossRefGoogle Scholar
  4. FDA (2004) Guidance for industry: PAT—a framework for innovative pharmaceutical manufacturing and quality assurance. http://www.fda.gov/cvm/guidance/published.html
  5. Gnoth S, Jenzsch M, Simutis R, Lübbert A (2007) Process analytical technology (PAT): batch-to-batch-reproducibility of fermentation processes by robust process operational design and control. J Biotechnol 132:180–186CrossRefGoogle Scholar
  6. Gnoth S, Simutis R, Lübbert A (2010) Selective expression of the soluble product fraction in Escherichia coli cultures employed in recombinant protein production processes. Appl Microbiol Biotechnol 87:2047–2058CrossRefGoogle Scholar
  7. Jang JD, Barford JP (2000) Effect of feed rate on growth rate and antibody production in the fed-batch culture of murine hybridoma cells. Cytotechnology 32:229–242CrossRefGoogle Scholar
  8. Jenzsch M, Gnoth S, Beck M, Kleinschmidt M, Simutis R, Lübbert A (2006) Open loop control of the biomass concentration within the growth phase of recombinant protein production processes. J Biotechnol 127:84–94CrossRefGoogle Scholar
  9. Kuwae S, Ohda T, Tamashima H (2005) Development of a fed-batch culture process for enhanced production of recombinant human antithrombin by Chinese hamster ovary cells. J Biosci Bioeng 100:502–510CrossRefGoogle Scholar
  10. Ljunggren J, Häggström L (1992) Glutamine limited fed-batch culture reduces the overflow metabolism of amino acids in myeloma cells. Cytotechnology 8:45–56CrossRefGoogle Scholar
  11. Ljunggren J, Häggström L (1994) Catabolic control of hybridoma cells by glucose and glutamine limited fed batch cultures. Biotechnol Bioeng 44:808–818CrossRefGoogle Scholar
  12. Miller WM, Blanch HW, Wilke CR (1988) A kinetic analysis of hybridoma growth and metabolism in batch and continuous suspension culture: effect of nutrient concentration, dilution rate, and pH. Biotechnol Bioeng 32:947–965CrossRefGoogle Scholar
  13. Robinson DK, Memmert KW (1991) Kinetics of recombinant immunoglobulin production by mammalian cells in continuous culture. Biotechnol Bioeng 38:972–976CrossRefGoogle Scholar
  14. Tremblay Md, Perrier M, Chavarie C, Archambault J (1993) Fed-batch culture of hybridoma cells: comparison of optimal control approach and closed loop strategies. Bioproc Eng 9:13–21CrossRefGoogle Scholar
  15. Wong DCF, Wong KTK, Goh LT, Heng CK, Yap MGS (2004) Impact of dynamic online fed-batch strategies on metabolism, productivity and N-glycosylation quality in CHO cell cultures. Biotechnol Bioeng 89:164–177CrossRefGoogle Scholar
  16. Wurm F (2004) Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 22(11):1393–1398CrossRefGoogle Scholar
  17. Xie L, Wang DIC (2006) Fed-batch cultivation of animal cells using different medium design concepts and feeding strategies. Biotechnol Bioeng 95:270–284CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • M. Aehle
    • 1
  • A. Kuprijanov
    • 1
  • S. Schaepe
    • 1
  • R. Simutis
    • 2
  • A. Lübbert
    • 1
    Email author
  1. 1.Institute of Biochemistry and BiotechnologyMartin-Luther-University Halle-WittenbergHalle (Saale)Germany
  2. 2.Institute of Automation and Control SystemsKaunas University of TechnologyKaunasLithuania

Personalised recommendations